Astrana Health (ASTH) Liabilities and Shareholders Equity (2011 - 2026)

Astrana Health (ASTH) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $2.4 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 77.19% year-over-year to $2.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 billion (up 58.06% YoY) and the FY2025 annual result came in at $2.2 billion, up 63.75% from the prior year.
• Liabilities and Shareholders Equity grew to $2.4 billion in Q1 2026 per ASTH's latest filing, from $2.2 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $2.4 billion in Q1 2026, with the low at $922.7 million in Q1 2022.
• Average Liabilities and Shareholders Equity over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2024.
• Year-over-year, Liabilities and Shareholders Equity slipped 3.4% in 2023 and soared 77.19% in 2026.
• Astrana Health's Liabilities and Shareholders Equity stood at $966.2 million in 2022, then fell by 3.4% to $933.4 million in 2023, then surged by 45.16% to $1.4 billion in 2024, then soared by 63.75% to $2.2 billion in 2025, then advanced by 6.32% to $2.4 billion in 2026.
• Business Quant data shows ASTH's Liabilities and Shareholders Equity at $2.4 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.2 billion in Q3 2025.